Why this matters
Learn the difference between a cardiovascular risk marker and a treatment that prevents events.
How the pieces connect
Blood-vessel function, clotting, and inflammation may relate to risk. Compare studies of risk with trials that measure heart attacks or strokes.
Association is not the same as prevention
An observational study can find that higher homocysteine accompanies greater cardiovascular risk. A treatment study asks a different question: does an intervention reduce events? Differences in study design, underlying illness and the chosen outcome matter. Read a reported change in homocysteine beside the actual cardiovascular outcomes, rather than assuming one is a substitute for the other. Risk assessment also extends beyond a single metabolic marker.
Keep in mind
Lowering homocysteine has usually not prevented heart attacks or strokes in treatment studies. Ask whether testing this marker would help with your own care.
A question for your next conversation
Did the intervention improve health outcomes, or only the laboratory number?
BUILD YOUR UNDERSTANDING
A few concepts, made clearer.
LET YOUR CURIOSITY LEAD
One idea opens another.
Choose a subject to find the related teaching across videos, articles, courses and references.






